Related Articles
Primary central nervous system lymphoma treated with high‑dose methotrexate and rituximab: A single‑institution experience
Curative effect of methotrexate combined with teniposide in the treatment of primary central nervous system lymphoma
Tailored therapy for aggressive non-Hodgkin's lymphoma: results of a phase II study with a long-term follow-up.
Phase 2 study of CHOP‑R‑14 followed by 90Y‑ibritumomab tiuxetan in patients with previously untreated diffuse large B‑cell lymphoma
Comparison of the outcomes of patients with primary central nervous system lymphoma between the neurosurgery and hematology/oncology departments based on the relative dose intensity of methotrexate